# Triple Versus Quadruple Therapy for the Eradication of Helicobacter Pylori

> **NCT06299605** · NA · UNKNOWN · sponsor: **Shandong University** · enrollment: 375 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Vonoprazan-Amoxicillin-Tetracycline-Bismuth quadruple regimen for 14 days
- **DRUG:** Vonoprazan-Amoxicillin-Tetracycline triple regimen for 14 days
- **DRUG:** Vonoprazan-Amoxicillin-Tetracycline triple regimen for 7 days

## Key facts

- **NCT ID:** NCT06299605
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-11-27
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-11-30
- **Target enrollment:** 375 (ESTIMATED)
- **Last updated:** 2024-12-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06299605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06299605, "Triple Versus Quadruple Therapy for the Eradication of Helicobacter Pylori". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06299605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*